Aclaris Therapeutics
ACRS
ACRS
95 hedge funds and large institutions have $227M invested in Aclaris Therapeutics in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
21% less capital invested
Capital invested by funds: $289M → $227M (-$61.5M)
76% less call options, than puts
Call options by funds: $68K | Put options by funds: $288K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
95
Holding in Top 10
–
Calls
$68K
Puts
$288K
Top Buyers
| 1 | +$6.69M | |
| 2 | +$3.27M | |
| 3 | +$3.11M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$2.22M |
| 5 |
Renaissance Technologies
New York
|
+$1.99M |
Top Sellers
| 1 | -$5.96M | |
| 2 | -$5.53M | |
| 3 | -$4.54M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.8M |
| 5 |
BlackRock
New York
|
-$2.92M |